Type of Study:

Interventional

Study Design:

Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Maturation rate of oocytes, their fertilization rate, cleavage rate and embryo quality.

Outcome Time Frame:

one year

Principal Investigator

Adrian Ellenbogen, MD

Investigator Role:

Study Director

Investigator Affiliation:

IVF Unit, Hillel Yaffe Medical Center

Authority:

Israel: Israeli Health Ministry Pharmaceutical Administration

Study ID:

30/2007

NCT ID:

NCT00561808

Start Date:

January 2008

Completion Date:

January 2009

Related Keywords:

• Polycystic Ovarian Syndrome
• PCO/PCOD
• IVM
• Immature Oocytes
• Polycystic Ovary Syndrome